CN106619761A - 一种缓解牙痛的止痛药 - Google Patents
一种缓解牙痛的止痛药 Download PDFInfo
- Publication number
- CN106619761A CN106619761A CN201611010574.2A CN201611010574A CN106619761A CN 106619761 A CN106619761 A CN 106619761A CN 201611010574 A CN201611010574 A CN 201611010574A CN 106619761 A CN106619761 A CN 106619761A
- Authority
- CN
- China
- Prior art keywords
- parts
- anodyne
- toothache
- aceclofenac
- tamoxifen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/732—Pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明公开了一种缓解牙痛的止痛药,所述缓解牙痛的止痛药,按照重量份的主要原料为:非那西丁13‑18份、醋氯芬酸2‑6份、三七粉10‑20份、吲哚美辛13‑15份、葡醛内酯4‑9份、果胶2‑6份、鼠李铋镁0.2‑0.7份、三苯氧氨5‑8份、枸橼酸钠2‑8份。本发明主要医治蛀牙痛、风火牙痛、牙周炎、神经性牙痛、细菌性感染牙痛等病,使用时,只要将本成品药涂敷于患病处,在3‑5秒钟内解除牙痛,达到理想治疗效果。
Description
技术领域
本发明涉及一种医药制备领域,具体是一种缓解牙痛的止痛药。
背景技术
牙齿是一种在很多脊椎动物上存在的结构,牙齿是人类身体最坚硬的器官。人的一生有两副天然牙,一副是乳牙,一副是恒牙。乳牙掉了后,便长出了恒牙。恒牙掉后不能再生。随着社会科技的进步与发展,义齿成为人类的第三副牙。人们在日常生活中,通过牙齿的配合进行发声说话、咀嚼饮食等行为。同时,牙齿的健康、美观也与咱们的日常各方面紧密相关。每个牙都分为牙冠、牙根和牙颈三部分。牙冠是露出于口腔的部分,洁白而有光泽;牙根嵌于牙槽内,借牙周膜与骨质结合,牙根尖部有一孔,称为牙根尖孔,有血管、神经出入,牙颈为牙冠和牙根间稍细的部分,外包以牙龈。牙的构造主要是由牙质构成,在牙根部牙质的外面包有一层粘合质(牙骨质),而在牙冠部表面有白色、光亮、坚硬的釉质。釉质是人体中钙化程度最高的组织。牙内部的腔隙称为牙腔,牙腔内充满血管、神经和结缔组织,称为牙髓。口腔内的乳酸杆菌能使糖类酵解产酸,导致釉质脱钙,产生空洞,临床称为龋齿。若龋洞不断加深,波及牙髓的神经,则可引起剧痛。牙痛是指牙齿因各种原因引起的疼痛,为口腔疾患中常见的症状之一,可见于龋齿、牙髓炎、根尖周炎、牙外伤、牙本质过敏、楔状缺损等。牙痛大多由牙龈炎和牙周炎、龋齿(蛀牙)或折裂牙而导致牙髓(牙神经)感染所引起的。是由于不注意口腔卫生,牙齿受到牙齿周围食物残渣、细菌等物结成的软质的牙垢和硬质的牙石所致的长期刺激,及不正确的刷牙习惯,维生素缺乏等原因所造成。
因此,急需研发一种适合疗效好、速度快、价格低、无毒副作用的止痛药。
发明内容
本发明的目的在于提供一种缓解牙痛的止痛药,以解决上述背景技术中提出的问题。
为实现上述目的,本发明提供如下技术方案:
一种缓解牙痛的止痛药,按照重量份的主要原料为:非那西丁13-18份、醋氯芬酸2-6份、三七粉10-20份、吲哚美辛13-15份、葡醛内酯4-9份、果胶2-6份、鼠李铋镁0.2-0.7份、三苯氧氨5-8份、枸橼酸钠2-8份。
作为本发明进一步的方案:所述缓解牙痛的止痛药,按照重量份的主要原料为:非那西丁14-16份、醋氯芬酸3-5份、三七粉13-18份、吲哚美辛13-15份、葡醛内酯5-8份、果胶2-6份、鼠李铋镁0.4-0.6份、三苯氧氨5-8份、枸橼酸钠3-6份。
作为本发明进一步的方案:所述缓解牙痛的止痛药,按照重量份的主要原料为:非那西丁15份、醋氯芬酸4份、三七粉16份、吲哚美辛14份、葡醛内酯7份、果胶4份、鼠李铋镁0.5份、三苯氧氨7份、枸橼酸钠5份。
一种缓解牙痛的止痛药的制备方法,具体步骤为:
首先,在医药级洁净区内,按上述计量比称取非那西丁、醋氯芬酸、三七粉、吲哚美辛、葡醛内酯、果胶、鼠李铋镁、三苯氧氨、枸橼酸钠,过筛,机械混匀后添加超纯水,放置制药混合机中,混合4-8min,控制RSD≤5%,混合后压片并低温干燥,温度控制在4-8℃,包装即得缓解牙痛的止痛药。
作为本发明进一步的方案:具体步骤中混合6min。
作为本发明进一步的方案:具体步骤中温度控制在6℃。
与现有技术相比,本发明的有益效果是:
本发明主要医治蛀牙痛、风火牙痛、牙周炎、神经性牙痛、细菌性感染牙痛等病,使用时,只要将本成品药涂敷于患病处,在3-5秒钟内解除牙痛,达到理想治疗效果。
具体实施方式
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
一种缓解牙痛的止痛药,按照重量份的主要原料为:非那西丁13份、醋氯芬酸2份、三七粉10份、吲哚美辛13份、葡醛内酯4份、果胶2份、鼠李铋镁0.2份、三苯氧氨5份、枸橼酸钠2份。
一种缓解牙痛的止痛药的制备方法,具体步骤为:
首先,在医药级洁净区内,按上述计量比称取非那西丁、醋氯芬酸、三七粉、吲哚美辛、葡醛内酯、果胶、鼠李铋镁、三苯氧氨、枸橼酸钠,过筛,机械混匀后添加超纯水,放置制药混合机中,混合4min,控制RSD≤5%,混合后压片并低温干燥,温度控制在4℃,包装即得缓解牙痛的止痛药。
实施例2
一种缓解牙痛的止痛药,按照重量份的主要原料为:非那西丁14份、醋氯芬酸3份、三七粉13份、吲哚美辛13份、葡醛内酯5份、果胶2份、鼠李铋镁0.4份、三苯氧氨5份、枸橼酸钠3份。
一种缓解牙痛的止痛药的制备方法,具体步骤为:
首先,在医药级洁净区内,按上述计量比称取非那西丁、醋氯芬酸、三七粉、吲哚美辛、葡醛内酯、果胶、鼠李铋镁、三苯氧氨、枸橼酸钠,过筛,机械混匀后添加超纯水,放置制药混合机中,混合4min,控制RSD≤5%,混合后压片并低温干燥,温度控制在4℃,包装即得缓解牙痛的止痛药。
实施例3
一种缓解牙痛的止痛药,按照重量份的主要原料为:非那西丁15份、醋氯芬酸4份、三七粉16份、吲哚美辛14份、葡醛内酯7份、果胶4份、鼠李铋镁0.5份、三苯氧氨7份、枸橼酸钠5份。
一种缓解牙痛的止痛药的制备方法,具体步骤为:
首先,在医药级洁净区内,按上述计量比称取非那西丁、醋氯芬酸、三七粉、吲哚美辛、葡醛内酯、果胶、鼠李铋镁、三苯氧氨、枸橼酸钠,过筛,机械混匀后添加超纯水,放置制药混合机中,混合6min,控制RSD≤5%,混合后压片并低温干燥,温度控制在6℃,包装即得缓解牙痛的止痛药。
实施例4
一种缓解牙痛的止痛药,按照重量份的主要原料为:非那西丁16份、醋氯芬酸5份、三七粉18份、吲哚美辛15份、葡醛内酯8份、果胶6份、鼠李铋镁0.6份、三苯氧氨8份、枸橼酸钠6份。
一种缓解牙痛的止痛药的制备方法,具体步骤为:
首先,在医药级洁净区内,按上述计量比称取非那西丁、醋氯芬酸、三七粉、吲哚美辛、葡醛内酯、果胶、鼠李铋镁、三苯氧氨、枸橼酸钠,过筛,机械混匀后添加超纯水,放置制药混合机中,混合8min,控制RSD≤5%,混合后压片并低温干燥,温度控制在8℃,包装即得缓解牙痛的止痛药。
实施例5
一种缓解牙痛的止痛药,按照重量份的主要原料为:非那西丁18份、醋氯芬酸6份、三七粉20份、吲哚美辛15份、葡醛内酯9份、果胶6份、鼠李铋镁0.7份、三苯氧氨8份、枸橼酸钠8份。
一种缓解牙痛的止痛药的制备方法,具体步骤为:
首先,在医药级洁净区内,按上述计量比称取非那西丁、醋氯芬酸、三七粉、吲哚美辛、葡醛内酯、果胶、鼠李铋镁、三苯氧氨、枸橼酸钠,过筛,机械混匀后添加超纯水,放置制药混合机中,混合8min,控制RSD≤5%,混合后压片并低温干燥,温度控制在8℃,包装即得缓解牙痛的止痛药。
临床试验
1、病例来源
在四川大学华西口腔医院门诊部筛选300例牙痛志愿患者,男150例,女150例,年龄12~65岁,平均年龄40.7岁,火牙患者213例,龋齿患者204例,牙周炎75例,牙髓炎56例,牙本质过敏82例,牙疼表现为:持续性或间歇性疼痛、牙龈红肿、部分有出血现象,患者牙痛时间最短一天,最长17天,平均7.4天。将所有患者平均分为5组,各组患者无统计学差异。
2、治疗方法上述5组患者分别按照本发明的方法服用上述实施例3制备的止痛药,3日为一疗程,每天2次,每次1g,观察一疗程后治疗结果。
3、疗效标准显效:牙齿疼痛、红肿出血等临床症状全部消失;有效:牙痛发作次数以及发作时疼痛的程度比治疗前明显减轻。无效:治疗前后症状无明显变化或加重。
4、结果:实施例3制备的止痛药,显效总人数为287例,有效人数为8例,无效人数为5例,总有效率为98.3%。
对于本领域技术人员而言,显然本发明不限于上述示范性实施例的细节,而且在不背离本发明的精神或基本特征的情况下,能够以其他的具体形式实现本发明。因此,无论从哪一点来看,均应将实施例看作是示范性的,而且是非限制性的,本发明的范围由所附权利要求而不是上述说明限定,因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。
此外,应当理解,虽然本说明书按照实施方式加以描述,但并非每个实施方式仅包含一个独立的技术方案,说明书的这种叙述方式仅仅是为清楚起见,本领域技术人员应当将说明书作为一个整体,各实施例中的技术方案也可以经适当组合,形成本领域技术人员可以理解的其他实施方式。
Claims (6)
1.一种缓解牙痛的止痛药,其特征在于,按照重量份的主要原料为:非那西丁13-18份、醋氯芬酸2-6份、三七粉10-20份、吲哚美辛13-15份、葡醛内酯4-9份、果胶2-6份、鼠李铋镁0.2-0.7份、三苯氧氨5-8份、枸橼酸钠2-8份。
2.根据权利要求1所述的缓解牙痛的止痛药,其特征在于,所述缓解牙痛的止痛药,按照重量份的主要原料为:非那西丁14-16份、醋氯芬酸3-5份、三七粉13-18份、吲哚美辛13-15份、葡醛内酯5-8份、果胶2-6份、鼠李铋镁0.4-0.6份、三苯氧氨5-8份、枸橼酸钠3-6份。
3.根据权利要求1或2所述的缓解牙痛的止痛药,其特征在于,所述缓解牙痛的止痛药,按照重量份的主要原料为:非那西丁15份、醋氯芬酸4份、三七粉16份、吲哚美辛14份、葡醛内酯7份、果胶4份、鼠李铋镁0.5份、三苯氧氨7份、枸橼酸钠5份。
4.一种如权利要求1-3任一所述的缓解牙痛的止痛药的制备方法,其特征在于,具体步骤为:
首先,在医药级洁净区内,按上述计量比称取非那西丁、醋氯芬酸、三七粉、吲哚美辛、葡醛内酯、果胶、鼠李铋镁、三苯氧氨、枸橼酸钠,过筛,机械混匀后添加超纯水,放置制药混合机中,混合4-8min,控制RSD≤5%,混合后压片并低温干燥,温度控制在4-8℃,包装即得缓解牙痛的止痛药。
5.根据权利要求4所述的缓解牙痛的止痛药的制备方法,其特征在于,具体步骤中混合6min。
6.根据权利要求4所述的缓解牙痛的止痛药的制备方法,其特征在于,具体步骤中温度控制在6℃。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611010574.2A CN106619761A (zh) | 2016-11-17 | 2016-11-17 | 一种缓解牙痛的止痛药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611010574.2A CN106619761A (zh) | 2016-11-17 | 2016-11-17 | 一种缓解牙痛的止痛药 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106619761A true CN106619761A (zh) | 2017-05-10 |
Family
ID=58807309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611010574.2A Withdrawn CN106619761A (zh) | 2016-11-17 | 2016-11-17 | 一种缓解牙痛的止痛药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106619761A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107456493A (zh) * | 2017-08-07 | 2017-12-12 | 周从勇 | 一种用于口腔手术后减缓水肿反应的止痛药 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1813765A (zh) * | 2005-12-06 | 2006-08-09 | 马清波 | 一种治疗牙痛的药物 |
CN100484535C (zh) * | 2005-10-24 | 2009-05-06 | 王明贤 | 治疗牙痛的药物 |
-
2016
- 2016-11-17 CN CN201611010574.2A patent/CN106619761A/zh not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100484535C (zh) * | 2005-10-24 | 2009-05-06 | 王明贤 | 治疗牙痛的药物 |
CN1813765A (zh) * | 2005-12-06 | 2006-08-09 | 马清波 | 一种治疗牙痛的药物 |
Non-Patent Citations (1)
Title |
---|
刘松青: "《实用药物手册》", 31 October 2007, 四川大学出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107456493A (zh) * | 2017-08-07 | 2017-12-12 | 周从勇 | 一种用于口腔手术后减缓水肿反应的止痛药 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kusum et al. | Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth | |
CN108670889A (zh) | 一种防治口腔溃疡的牙膏及其制备方法 | |
CN105267104A (zh) | 一种治疗牙周炎的天然植物牙膏及其制备方法 | |
Heithersay | Life cycles of traumatized teeth: long‐term observations from a cohort of dental trauma victims | |
Chibinski | The use of silver diamine fluoride in pediatric dentistry | |
CN106619761A (zh) | 一种缓解牙痛的止痛药 | |
CN106619676A (zh) | 一种用于缓解牙痛的止痛药 | |
Symons et al. | Pulpal obliteration related to long‐term glucocorticosteroid medication | |
CN102784209A (zh) | 一种预防和治疗牙齿敏感的中药组合物及其牙膏和制备方法 | |
RU2188627C1 (ru) | Состав для профилактики заболеваний полости рта | |
Skikevych et al. | The basics of stomatology | |
Nešković et al. | Importance of using probiotics in children dental caries prevention | |
Sreshtaa et al. | Dietary Capsaicin and Immune System | |
TWI730287B (zh) | 口腔用組合物及其製備方法與用途 | |
AU2019100472A4 (en) | Methods and compositions for treating gingivitis and inflammation and reducing plaque and tartar | |
Ungureanu et al. | Prevention in dental medicine: case studies and explanations regarding the cost-benefit ratio | |
Garrocho-Rangel et al. | Direct pulp capping in primary molars with enamel matrix derivative: report of a case | |
Handoko | The 1st Bali International Dental Symposium | |
RU2542469C1 (ru) | Средство для местной терапии рецидивирующих афт полости рта при стоматите зубных рядов и пародонтите | |
CN1543926A (zh) | 一种治疗口腔疾病的药物牙膏 | |
FAIZ et al. | Role Of Lateral Incisors In Female-An Impact Towards Attractiveness Of Smile | |
Albeshr et al. | Oral Health Care Challenges for Older Adults a Review | |
Furnadzhieva et al. | Oral cavity changes during and aftercancer therapy | |
Dwiyanti et al. | Preoperative Oral Health Screening Prior to Cardiovascular Intervention: A Case Report | |
Ryabokon et al. | Practically-oriented examination. The collection of test questions providing the preparation for the licensing exam “KROK-2. Dentistry” in therapeutic dentistry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170510 |